Closing Bell: Medexus Pharmaceuticals Inc down on Monday (MDP)

Today, Medexus Pharmaceuticals Inc opened at $2.23 and closed at $2.21. Intraday prices ranged from $2.20 to $2.29.

The price eased -2.21% from the previous day's close of $2.26.

Today across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

Trading volume was 17,870 on 40 total trades, with an average volume of 16,932 in the last five days.

Trading across the entire TSX saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have gained 7.28 percent in the last 12 months, while this year, they have reduced -10.53%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $55.28 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Medexus Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..